The Global Paediatric Influenza Treatment Industry is on the brink of a significant evolution, projecting a remarkable surge from US$ 578.2 million in 2022 to an impressive US$ 847.7 million by 2032. Fueled by a robust Compound Annual Growth Rate (CAGR) of 3.5% over the forecast period from 2022 to 2032, this growth paints a …